Centrix Pharmaceutical, Inc. Trademark Portfolio
Centrix Pharmaceutical, Inc. owns 2 live USPTO trademarks across 1 Nice classes. Earliest filing: 2004-09-29; most recent: 2013-01-31.
Portfolio Summary
Centrix Pharmaceutical's portfolio tells the story of a small pharma company that struggled to secure and defend its brand identity. With an alarmingly low 10% registration rate and 18 of 20 marks now dead — all concentrated exclusively in Class 005 — this is not a company that failed to file but one that repeatedly failed to clear substantive hurdles. The two ex parte appeals filed simultaneously in 2008 suggest the USPTO refused registration on multiple applications, and Centrix lost both, signaling either poor clearance work upfront or a willingness to file aspirational marks in a crowded pharmaceutical space without adequate distinctiveness or freedom-to-operate analysis.
The TTAB record reveals a company that was
Portfolio Overview
| Total Marks | 20 |
|---|---|
| Live Marks | 2 |
| Registered | 2 |
| Pending | 0 |
| Earliest Filing | 2004-09-29 |
| Latest Filing | 2013-01-31 |
Top Classes
Recently Registered Marks
Recently Filed Applications
- CENTRIX PHARMACEUTICAL, INC. — filed 2013-01-31 (Cancelled)
- CP CENTRIX PHARMACEUTICAL, INC. — filed 2012-08-02 (Cancelled)
- PLURATUSS — filed 2009-12-11 (Cancelled)
- PAIREOB — filed 2009-07-16 (Cancelled)
- UNIPAIRE — filed 2009-05-29 (Abandoned)
Top Marks
- CP CENTRIX PHARMACEUTICAL, INC. — Cancelled
- CENTRIX PHARMACEUTICAL, INC. — Cancelled
- PAIREOB — Cancelled
- CP — Cancelled
- PLURATUSS — Cancelled
- CLOFERA — Cancelled
- CP — Cancelled
- TENAR — Cancelled
- MAXARON — Cancelled
- CP — Registered
- COVARYX — Registered
- DICEL — Cancelled
- CENTRIX — Cancelled
- UNIPAIRE — Abandoned
- XYFENYX — Abandoned
- CP — Abandoned
- CENTRIX — Abandoned
- PAIRE-OB — Abandoned
- UTRIX — Abandoned
- PLEXASE — Abandoned